CompletedPhase 3NCT02746991
Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis
Studying Infectious panuveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Principal Investigator
- Flavio Leonin Jr., MDEyePoint Pharmaceuticals, Inc.
- Intervention
- Sham Injection(drug)
- Enrollment
- 153 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2019
Study locations (15)
- LV. Prasad Eye Institute, Hyderabad, Andhra Pradesh, India
- Sri Sankaradeva Nethralaya, Guwahati, Guwahati, Assam, India
- Regional Institute of Opthalmology, Patna, Bihar, India
- C.H. Nagri Municipal Eye Hospital, Ahmedabad, Gujarat, India
- Seth G.S. Medical College & K.E.M Hospital, Mumbai, Maharashtra, India
- Deenanath Mangeshkar Hospital, Pune, Pune, Maharashtra, India
- PBMA'S, H. V. Desai Eye Hospital, Pune, Maharashtra, India
- Dr. Shroff's Charity Eye Hospital, Daryāganj, New Delhi, India
- Sankara Nethralaya hospital, Chennai, Tamil Nadu, India
- Vasan Eye Care Hospital, Chennai, Tamil Nadu, India
- Sri Ramachandra Hospital, Chennai, Tamil Nadu, India
- J L Rohatgi Memorial Eye Hospital, Kanpur, Uttar Pradesh, India
- King George's Medical University, Lucknow, Uttar Pradesh, India
- ICARE Eye Hospital and Research centre, Noida, Uttar Pradesh, India
- Regional Institute of Ophthalmology, Kolkata, West Bengal, India
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02746991 on ClinicalTrials.gov